In the present study, our data showed that the genomic sequence ofBCR-ABL was almost completely eliminated by this strategy, and the level of the BCR-ABL fusion protein was reduced significantly, leading to the inhibition of CML cell line proliferation and increased cell apoptosisin vitro andin vivo. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.